Cardiovascular Catheters Market Report 2024

This Cardiovascular Catheters market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The cardiovascular catheters market size has grown strongly in recent years. It will grow from $18.44 billion in 2023 to $20.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be attributed to increased funding for research and development, a rise in the use of catheters in electrophysiology (EP) procedures, the expansion of cardiac catheterization labs in hospitals, a higher number of interventional cardiology procedures, and an increase in the prevalence of diabetes.

The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $28.17 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to efforts to reduce healthcare costs, the adoption of hybrid operating rooms, increased investment in cardiovascular research from both public and private sectors, the rising use of drug-eluting catheters, and the development and adoption of biodegradable catheter materials. Key trends expected to drive this growth include the integration of AI in catheter-based procedures, advancements in imaging technologies, the development of miniaturized catheters, the adoption of robotic-assisted catheter procedures, and the creation of wireless, battery-free catheters.

The rising prevalence of vascular heart diseases is expected to drive the growth of the cardiovascular catheter market in the future. Vascular heart diseases include various conditions affecting the blood vessels that supply the heart or within the heart itself. Contributing factors such as poor lifestyle habits, aging populations, and increasing rates of diabetes and hypertension are leading to more cases of these diseases. Cardiovascular catheters are essential for patients with vascular heart conditions as they enable minimally invasive procedures to diagnose, treat, and manage issues such as blocked arteries and irregular heart rhythms, resulting in quicker recovery and better outcomes. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that cardiovascular disease-related deaths reached 931,578, up from 928,741 in 2023. The age-adjusted death rate from cardiovascular diseases also saw a slight increase to 233.3 per 100,000, marking a 4% rise from the previous year's rate of 224.4 per 100,000. This growing prevalence of vascular heart diseases is driving the demand for cardiovascular catheters.

Key players in the cardiovascular catheters market are focusing on developing advanced technologies, such as TRUEref technology, to improve the accuracy and reliability of cardiac mapping. TRUEref technology enhances cardiovascular catheters by providing precise reference signals during cardiac mapping, which improves arrhythmia detection and enables more targeted treatments. For example, in July 2023, Biosense Webster Inc., a US-based company and part of Johnson & Johnson MedTech, introduced the OPTRELL mapping catheter featuring TRUEref technology. This high-density diagnostic catheter, powered by the CARTO 3 System, provides high-definition electrophysiological mapping with 48 small electrodes, allowing clinicians to map complex cardiac arrhythmias with greater precision and develop more effective ablation strategies.

In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott's portfolio of vascular devices with Cardiovascular Systems' advanced atherectomy system, thus improving treatment options for peripheral and coronary artery diseases. The acquisition will enable Abbott to offer more comprehensive care for patients with complex arterial conditions. Cardiovascular Systems Inc., based in the US, specializes in developing and commercializing catheters and other devices for treating peripheral and coronary artery diseases.

Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV.

Asia-Pacific was the largest region in the cardiovascular catheters market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cardiovascular catheters are flexible, slender tubes inserted into blood vessels for diagnostic or therapeutic procedures within the heart and vascular system. They are crucial for delivering treatments, monitoring blood flow, and evaluating heart conditions, and they play a vital role in minimally invasive procedures, enabling access to the heart and blood vessels without the need for open surgery.

The cardiovascular catheters market primarily includes two types of products, cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are designed for minimally invasive procedures aimed at treating heart and blood vessel conditions, such as clearing blocked arteries or correcting abnormal heart rhythms. These catheters are used in various applications, including coronary artery disease (CAD), cardiac arrhythmia, and heart failure, and are utilized by hospitals, clinics, and ambulatory surgical centers.

The cardiovascular catheters market research report is one of a series of new reports that provides cardiovascular catheters market statistics, including the cardiovascular catheters industry global market size, regional shares, competitors with cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. These cardiovascular catheters market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.